Present and future management of viral hepatitis

doi:10.3748/wjg.v27.i47.8081

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6046)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

480

WORD

208

HTML

3950

Figures (1-3)

351

Tables (1-2)

278

Sum=5267

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

334

Download

445

Sum=779

Dec 21, 2021 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Dec 21, 2021; 27(47): 8081-8102
Published online Dec 21, 2021. doi: 10.3748/wjg.v27.i47.8081

Full Size Figure Download Figure

Figure 1 The main therapeutic targets and the drugs under development for hepatitis B. HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; cccDNA: Covalently closed circular DNA.

Citation: González Grande R, Santaella Leiva I, López Ortega S, Jiménez Pérez M. Present and future management of viral hepatitis. World J Gastroenterol 2021; 27(47): 8081-8102
URL: https://www.wjgnet.com/1007-9327/full/v27/i47/8081.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i47.8081